Drug Development


Flonase-072914.jpg The FDA has approved an over-the-counter formulation of the drug Flonase aimed specifically at allergy relief. The drug, produced by GlaxoSmithKline, will be the second major nasal steroid approved for over the counter sales by the FDA. The first such drug approved by the agency was Nasacort 24Hr and both drugs are approved for symptoms including nasal congestion, runny nose, sneezing and more.

img4-072814.jpg Alcon's Simbrinza has been approved in the European Union to treat those living with glaucoma. The drug combines two approved therapies, Brinzolamide 10mg/mL and Brimonidine 2mg/mL, in one eye drop formula. Glaucoma is a group of diseases that damage the eye's optic nerve and can result in vision loss and blindness.

Acetaminophen-080513.jpg Acetaminophen may not help treat lower-back pain, according to research conducted at the University of Sydney. The study, published in the journal the Lancet, collected data on over 1,600 people diagnosed with acute back pain. Researchers gave one group a placebo pill and another group acetaminophen and found that the latter offered no substantial pain relief compared to the former.

letroz-071014.jpg Letrozole (Femara), an aromatase inhibitor commonly used to treat breast cancer, has also shown promise as a fertility treatment, according to a new study from researchers at the Cleveland Clinic. For the study the researchers carried out a double blind test of the drug with 750 women between the ages of 18 and 40. The drug was compared to a commonly used estrogen receptor drug.

pen-061714.jpg Victoza, a diabetes drug developed by Novo Nordisk, may help with appetite suppression and weight loss, according to research conducted by the pharm maker. The study, presented at the American Diabetes Association meeting in San Francisco, surveyed 846 overweight or obese adults with type 2 diabetes over a 56-week period.